Dawnrays Pharmaceutical (Holdings) Limited

SEHK:2348 Stock Report

Mkt Cap: HK$2.0b

Dawnrays Pharmaceutical (Holdings) Past Performance

How has Dawnrays Pharmaceutical (Holdings) performed over the past 5 years?

Past Performance Score


Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 2348 has high quality earnings.

Growing Profit Margin: 2348's current net profit margins (30.8%) are higher than last year (26.7%).

Past Earnings Growth Analysis

Earnings Trend: 2348's earnings have grown by 2.9% per year over the past 5 years.

Accelerating Growth: 2348's earnings growth over the past year (19%) exceeds its 5-year average (2.9% per year).

Earnings vs Industry: 2348 earnings growth over the past year (19%) exceeded the Pharmaceuticals industry 5.2%.

Return on Equity

High ROE: 2348's Return on Equity (14.5%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies